Welcome to the Drug Delivery Lab!
Administration of free drug to treat diseases, in many cases, is associated with critical drawbacks like off-target effects and low in vivo stability. This hinders the treatment of the disease. With our versatile expertise, we aim to reduce these shortcomings. Our lab focuses on using wide range of tools and concepts such as nano- and micro-particles, hydrogels, scaffolds and 3D organoids to generate treatment for diseases like Tuberculosis and Osteoarthritis. With our translational outlook, we plan to create clinically viable therapeutic options to treat such diseases.

Latest News

    • 20th Nov 2020
      Yeswanth's manuscript has been accepted in Frontiers in Microbiology! Also check out his interview with Bio Patrika here.
    • 1st Nov 2020
      Avijit has been awarded the DBT-research associate fellowship. Congratulations!
    • 7th Sep 2020
      Avijit Goswami and Priyanka Naik joins the laboratory as research associate and project associate respectively. Welcome!

Latest Publications

  • Kalapala Y.C.; Sharma P.R.; Agarwal R., Antimycobacterial potential of Mycobacteriophage under disease-mimicking conditions. Frontiers in Microbiology. 11 (2020) 583661
  • Dhanabalan K.M.; Gupta V.K.; Agarwal, R., Rapamycin-PLGA microspheres induce autophagy and prevent senescence in chondrocytes and exhibit prolonged retention in mice joints. Biomaterials Science. 8 (2020) 4308 – 4321